Factors associated with progression of depression, anxiety, and stress-related symptoms in outpatients and inpatients with COVID-19: A longitudinal study
Corresponding Author
Yasemin Hoşgören Alıcı
School of Medicine, Department of Psychiatry, Baskent University, Ankara, Turkey
Correspondence
Yasemin Hoşgören Alıcı, School of Medicine, Department of Psychiatry, Baskent University, Ankara, Turkey Fevzi çakmak Caddesi 10. Street 38/9 Bahçelievler, Çankaya, Ankara 06490, Turkey
Email: [email protected]
Search for more papers by this authorGüle Çınar
School of Medicine, Department of Infectious Disease, Ankara University, Ankara, Turkey
Search for more papers by this authorJamal Hasanlı
School of Medicine, Department of Psychiatry, Baskent University, Ankara, Turkey
Search for more papers by this authorSelvi Ceran
School of Medicine, Department of Psychiatry, Baskent University, Ankara, Turkey
Search for more papers by this authorDeha Onar
School of Medicine, Department of Psychiatry, Ankara University, Ankara, Turkey
Search for more papers by this authorEzgi Gülten
School of Medicine, Department of Infectious Disease, Ankara University, Ankara, Turkey
Search for more papers by this authorİrem Akdemir Kalkan
School of Medicine, Department of Infectious Disease, Ankara University, Ankara, Turkey
Search for more papers by this authorKemal Osman Memikoğlu
School of Medicine, Department of Infectious Disease, Ankara University, Ankara, Turkey
Search for more papers by this authorÇaşit Olgun Çelik
Department of Cardiology, Baskent University, Konya, Turkey
Search for more papers by this authorHalise Devrimci-Ozguven
School of Medicine, Department of Psychiatry, Ankara University, Ankara, Turkey
Search for more papers by this authorCorresponding Author
Yasemin Hoşgören Alıcı
School of Medicine, Department of Psychiatry, Baskent University, Ankara, Turkey
Correspondence
Yasemin Hoşgören Alıcı, School of Medicine, Department of Psychiatry, Baskent University, Ankara, Turkey Fevzi çakmak Caddesi 10. Street 38/9 Bahçelievler, Çankaya, Ankara 06490, Turkey
Email: [email protected]
Search for more papers by this authorGüle Çınar
School of Medicine, Department of Infectious Disease, Ankara University, Ankara, Turkey
Search for more papers by this authorJamal Hasanlı
School of Medicine, Department of Psychiatry, Baskent University, Ankara, Turkey
Search for more papers by this authorSelvi Ceran
School of Medicine, Department of Psychiatry, Baskent University, Ankara, Turkey
Search for more papers by this authorDeha Onar
School of Medicine, Department of Psychiatry, Ankara University, Ankara, Turkey
Search for more papers by this authorEzgi Gülten
School of Medicine, Department of Infectious Disease, Ankara University, Ankara, Turkey
Search for more papers by this authorİrem Akdemir Kalkan
School of Medicine, Department of Infectious Disease, Ankara University, Ankara, Turkey
Search for more papers by this authorKemal Osman Memikoğlu
School of Medicine, Department of Infectious Disease, Ankara University, Ankara, Turkey
Search for more papers by this authorÇaşit Olgun Çelik
Department of Cardiology, Baskent University, Konya, Turkey
Search for more papers by this authorHalise Devrimci-Ozguven
School of Medicine, Department of Psychiatry, Ankara University, Ankara, Turkey
Search for more papers by this authorAbstract
It is known that there is an increase in the frequency of psychiatric disturbances in the acute and post-illness phase of coronavirus disease (COVID-19). Comorbid psychiatric symptoms complicate the management of patients and negatively affect the prognosis, but there is no clear evidence of their progress. We aimed to determine psychiatric comorbidity in inpatients and outpatients with COVID-19 and recognize the factors that predict psychiatric comorbidity. For this purpose, we evaluated patients on the first admission and after 4 weeks. We investigated psychiatric symptoms in outpatients (n = 106) and inpatients (n = 128) diagnosed with COVID-19. In the first 7 days after diagnosis (first phase), sociodemographic and clinic data were collected, a symptom checklist was constructed, and the Hospital Anxiety and Depression Scale (HADS) and the Severity of Acute Stress Symptoms Scale (SASSS) were applied. After 30–35 days following the diagnosis, the SASSS and the HADS were repeated. In the first phase, the frequency of depression and anxiety were 55% and 20% in inpatients, and 39% and 18% in outpatients, respectively. In the second phase, depression scores are significantly decreased in both groups whereas anxiety scores were decreased only in inpatients. The frequencies of patients reporting sleep and attention problems, irritability, and suicide ideas decreased after 1 month. Patients with loss of smell and taste exhibit higher anxiety and depression scores in both stages. Our results revealed that the rate of psychiatric symptoms in COVID-19 patients improves within 1 month. Inpatients have a more significant decrease in both depression and anxiety frequency than do outpatients. The main factor affecting anxiety and depression was the treatment modality. Considering that all patients who were hospitalized were discharged at the end of the first month, this difference may be due to the elimination of the stress caused by hospitalization.
CONFLICT OF INTEREST
There is no conflict of interest.
Supporting Information
Filename | Description |
---|---|
pchJ557-sup-0001-TableS1.docxWord 2007 document , 15.7 KB | Appendix S1 Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- Ascibasi, K., Cokmus, F. P., & Aydemir, O. (2017). Reliability and validity of Turkish form of severity of acute stress symptoms scale/Dsm-5 Akut Stres Belirti Siddeti Olcegi Turkce Formunun Gecerliligi Ve Guvenilirligi. Anadolu Psikiyatri Dergisi, 18(S2), 38–45. https://doi.org/10.5455/Apd.237985
- Aydemir, Ö., Guvenir, T., Kuey, L., & Kultur, S. (1997). Validity and reliability of Turkish version of hospital anxiety and depression scale. Türk Psikiyatri Dergisi, 8(4), 280–287.
- Bao, C., Liu, X., Zhang, H., Li, Y., & Liu, J. (2020). Coronavirus disease 2019 (Covid-19) Ct findings: A systematic review and meta-analysis. Journal of the American College of Radiology, 17(6), 701–709. https://doi.org/10.1016/J.Jacr.2020.03.006
- Benitez, A., Gunstad, J., Hughes, J., Glickman, E., Alexander, T., Spitznagel, M. B., Juvancic-Heltzel, J., & Murray, L. (2009). Troponin and S100β are associated with depression in healthy older adults. Aging and Mental Health, 13(6), 894–898. https://doi.org/10.1080/13607860903046438
- Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020). The psychological impact of quarantine and how to reduce it: Rapid review of the evidence. The Lancet, 395(10227), 912–920. https://doi.org/10.1016/S0140-6736(20)30460-8
- Dantzer, R. (2018). Neuroimmune interactions: From the brain to the immune system and vice versa. Physiological Reviews, 98(1), 477–504. https://doi.org/10.1152/Physrev.00039.2016
- Debnath, M., Berk, M., & Maes, M. (2020). Changing dynamics of psychoneuroimmunology during the Covid-19 pandemic. Brain, Behavior, & Immunity-Health, 5, 100096. https://doi.org/10.1016/J.Bbih.2020.100096
- Deng, J., Zhou, F., Hou, W., Silver, Z., Wong, C. Y., Chang, O., Huang, E., & Zuo, Q. K. (2020). The prevalence of depression, anxiety, and sleep disturbances in Covid-19 patients: A meta-analysis. Annals of the New York Academy of Sciences, 1486(1), 90–111. https://doi.org/10.1111/Nyas.14506
- Erskine, S. E., & Philpott, C. M. (2020). An unmet need: Patients with smell and taste disorders. Clinical Otolaryngology, 45(2), 197–203. https://doi.org/10.1111/Coa.13484
- Feng, Y., Ling, Y., Bai, T., Xie, Y., Huang, J., Li, J., Xiong, W., Yang, D., Chen, R., & Lu, F. (2020). Covid-19 with different severities: A multicenter study of clinical features. American Journal of Respiratory and Critical Care Medicine, 201(11), 1380–1388. https://doi.org/10.1164/Rccm.202002-0445oc
- Hao, F., Tam, W., Hu, X., Tan, W., Jiang, L., Jiang, X., Zhang, L., Zhao, X., Zou, Y., & Hu, Y. (2020). A quantitative and qualitative study on the neuropsychiatric sequelae of acutely ill Covid-19 inpatients in isolation facilities. Translational Psychiatry, 10(1), 1–14. https://doi.org/10.1038/S41398-020-01039-2
- Huang, Y., & Zhao, N. (2020). Generalized anxiety disorder, depressive symptoms and sleep quality during Covid-19 outbreak in China: A web-based cross-sectional survey. Psychiatry Research, 288, 112954. https://doi.org/10.1016/J.Psychres.2020.112954
- Hur, K., Choi, J. S., Zheng, M., Shen, J., & Wrobel, B. (2018). Association of alterations in smell and taste with depression in older adults. Laryngoscope Investigative Otolaryngology, 3(2), 94–99. https://doi.org/10.1002/Lio2.142
- Kong, X., Zheng, K., Tang, M., Kong, F., Zhou, J., Diao, L., Wu, S., Jiao, P., Su, T., & Dong, Y. (2020). Prevalence and factors associated with depression and anxiety of hospitalized patients with Covid-19. Medrxiv. https://doi.org/10.1101/2020.03.24.20043075
10.1101/2020.03.24.20043075 Google Scholar
- Köhler-Forsberg, O., Buttenschøn, H. N., Tansey, K. E., Maier, W., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., & Rietschel, M. (2017). Association between C-reactive protein (Crp) with depression symptom severity and specific depressive symptoms in major depression. Brain, Behavior, and Immunity, 62, 344–350. https://doi.org/10.1016/J.Bbi.2017.02.020
- Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., & Distinguin, L. (2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (Covid-19): A multicenter European study. European Archives of Oto-Rhino-Laryngology, 277(8), 2251–2261. https://doi.org/10.1007/S00405-020-05965-1
- Liu, D., Baumeister, R. F., Veilleux, J. C., Chen, C., Liu, W., Yue, Y., & Zhang, S. (2020). Risk factors associated with mental illness in hospital discharged patients infected with Covid-19 in Wuhan, China. Psychiatry Research, 292, 113297. https://doi.org/10.1016/J.Psychres.2020.113297
- Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., & Rovere-Querini, P. (2020). Anxiety and depression in Covid-19 survivors: Role of inflammatory and clinical predictors. Brain, Behavior, and Immunity, 89, 594–600. https://doi.org/10.1016/J.Bbi.2020.07.037
- Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008). Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human Ace2. Journal of Virology, 82(15), 7264–7275. https://doi.org/10.1128/Jvi.00737-08
- Norton, S., Cosco, T., Doyle, F., Done, J., & Sacker, A. (2013). The hospital anxiety and depression scale: A meta confirmatory factor analysis. Journal of Psychosomatic Research, 74(1), 74–81. https://doi.org/10.1016/J.Jpsychores.2012.10.010
- Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020). Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain, Behavior, and Immunity, 87, 901–909. https://doi.org/10.1016/J.Bbi.2020.02.010
- Poyraz, B. Ç., Poyraz, C. A., Olgun, Y., Gürel, Ö., Alkan, S., Özdemir, Y. E., Balkan, İ. İ., & Karaali, R. (2021). Psychiatric morbidity and protracted symptoms after Covid-19. Psychiatry Research, 295, 113604. https://doi.org/10.1016/J.Psychres.2020.113604
- Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., Mcguire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the Covid-19 pandemic. The Lancet Psychiatry, 7(7), 611–627. https://doi.org/10.1016/S2215-0366(20)30203-0
- Sedaghat, A. R., Gengler, I., & Speth, M. M. (2020). Olfactory dysfunction: A highly prevalent symptom of Covid-19 with public health significance. Otolaryngology–Head and Neck Surgery, 163(1), 12–15. https://doi.org/10.1177/0194599820926464
- Speth, M. M., Singer-Cornelius, T., Oberle, M., Gengler, I., Brockmeier, S. J., & Sedaghat, A. R. (2020). Mood, anxiety and olfactory dysfunction in Covid-19: Evidence of central nervous system involvement? The Laryngoscope, 130(11), 2520–2525. https://doi.org/10.1002/Lary.28964
- Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Vives, A. H., & Cleare, A. (2015). Inflammation and clinical response to treatment in depression: A meta-analysis. European Neuropsychopharmacology, 25(10), 1532–1543. https://doi.org/10.1016/J.Euroneuro.2015.06.007
- Tomasoni, D., Bai, F., Castoldi, R., Barbanotti, D., Falcinella, C., Mulè, G., Mondatore, D., Tavelli, A., Vegni, E., & Marchetti, G. (2021). Anxiety and depression symptoms after Virological clearance of Covid-19: A cross-sectional study in Milan, Italy. Journal of Medical Virology, 93(2), 1175–1179. https://doi.org/10.1002/Jmv.26459
- Turan, Ş., Poyraz, B. Ç., Poyraz, C. A., Demirel, Ö. F., Aydın, E. T., Bostan, B. U., Demirel, Ö., & Ali, R. K. (2021). Characteristics and outcomes of Covid-19 inpatients who underwent psychiatric consultations. Asian Journal of Psychiatry, 57, 102563. https://doi.org/10.1016/J.Ajp.2021.102563
- von Känel, R., Bellingrath, S., & Kudielka, B. M. (2009). Association of vital exhaustion and depressive symptoms with changes in fibrin D-dimer to acute psychosocial stress. Journal of Psychosomatic Research, 67(1), 93–101.
- Wium-Andersen, M. K., Ørsted, D. D., Nielsen, S. F., & Nordestgaard, B. G. (2013). Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals. JAMA Psychiatry, 70(2), 176–184. https://doi.org/10.1001/2013.Jamapsychiatry.102
- Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020). Nervous system involvement after infection with Covid-19 and other coronaviruses. Brain, Behavior, and Immunity, 87, 18–22. https://doi.org/10.1016/J.Bbi.2020.03.031
- Xie, Q., Liu, X.-B., Xu, Y.-M., & Zhong, B.-L. (2021). Understanding the psychiatric symptoms of Covid-19: A meta-analysis of studies assessing psychiatric symptoms in Chinese patients with and survivors of Covid-19 and Sars by using the symptom Checklist-90-revised. Translational Psychiatry, 11(1), 1–10. https://doi.org/10.1038/S41398-021-01416-5
- Yan, C. H., Faraji, F., Prajapati, D. P., Boone, C. E., & Deconde, A. S. (2020). Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. International Forum Of Allergy & Rhinology, 10(7), 806–813. https://doi.org/10.1002/Alr.22579
- Zarghami, A., Farjam, M., Fakhraei, B., Hashemzadeh, K., & Yazdanpanah, M. H. (2020). A report of the Telepsychiatric evaluation of Sars-Cov-2 patients. Telemedicine and E-Health, 26(12), 1461–1465. https://doi.org/10.1089/Tmj.2020.0125
- Zhang, J., Lu, H., Zeng, H., Zhang, S., Du, Q., Jiang, T., & Du, B. (2020). The differential psychological distress of populations affected by the Covid-19 pandemic. Brain, Behavior, and Immunity, 87, 49–50. https://doi.org/10.1016/J.Bbi.2020.04.031
- Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. https://doi.org/10.1111/J.1600-0447.1983.Tb09716.X